Re: Prevalence of the Metabolic Syndrome and Cardiovascular Disease Risk in Chemotherapy-Treated Testicular Germ Cell Tumour Survivors Editorial Comment

被引：0
|
作者：
Seftel, Allen
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 190卷 / 05期
关键词：
D O I：
10.1016/j.juro.2013.07.096
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1768 / 1768
页数：1
相关论文
共 50 条
  • [1] Comment on ‘Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors’
    M Singhera
    R Huddart
    British Journal of Cancer, 2013, 109 : 2502 - 2503
  • [2] Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
    Singhera, M.
    Huddart, R.
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2502 - 2503
  • [3] Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors’
    P M Willemse
    J Burggraaf
    N A T Hamdy
    S Osanto
    British Journal of Cancer, 2013, 109 : 2503 - 2504
  • [4] Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
    Willemse, P. M.
    Burggraaf, J.
    Hamdy, N. A. T.
    Osanto, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2503 - 2504
  • [5] Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
    P M Willemse
    J Burggraaf
    N A T Hamdy
    N I Weijl
    C Y Vossen
    L van Wulften
    A Q M J van Steijn-van Tol
    F R Rosendaal
    S Osanto
    British Journal of Cancer, 2013, 109 : 60 - 67
  • [6] Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
    Willemse, P. M.
    Burggraaf, J.
    Hamdy, N. A. T.
    Weijl, N. I.
    Vossen, C. Y.
    van Wulften, L.
    van Steijn-van Tol, A. Q. M. J.
    Rosendaal, F. R.
    Osanto, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 60 - 67
  • [7] Erratum: Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
    P M Willemse
    J Burggraaf
    N A T Hamdy
    N I Weijl
    C Y Vossen
    L van Wulften
    A Q M J van Steijn-van Tol
    F R Rosendaal
    S Osanto
    British Journal of Cancer, 2013, 109 (1) : 295 - 296
  • [8] A RETROSPECTIVE AUDIT OF THE PREVALENCE OF CARDIOVASCULAR RISK AND METABOLIC SYNDROME IN PATIENTS WITH TREATED TESTICULAR GERM CELL TUMOURS
    Ladwa, R.
    Peters, G.
    Bigby, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 59 - 59
  • [9] Re: What is the Damage? Testicular Germ Cell Tumour Survivors Deficient in Testosterone at Risk of Metabolic Syndrome and a Need for Medical Intervention
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1517 - 1517
  • [10] Late relapse in chemotherapy-treated germ cell tumour patients
    Gerl, A
    Hentrich, M
    Clemm, C
    Schmeller, N
    Hartenstein, R
    Wilmanns, W
    GERM CELL TUMOURS IV, 1998, : 309 - 314
12345